Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irochel vs Deferoxamine for Transfusion-Induced Iron Overload in Thalassemia
NCT07782931Phase 3Completed
- Sponsor
- Hamdard University
- Start
- Feb 2019
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
A Phase 3 trial of Irochel in iron overload, sponsored by Hamdard University. Started Feb 2019; status: completed.
02
Drugs
Irochel
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT07782931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07782931.